… immunotherapeutic targets in NSCLC tumours and how the TME may influence patients'
response to immunotherapy… Different approaches to cancer immunotherapies have been …

… The goal of cancer immunotherapy is to elicit (or re-elicit) a cellular immune response,
especially the T-cell-mediated tumor-specific antigen (TSA) and tumor-associated antigens (TAA)-…

… lung cancer. Here, we will summarize the current state of immunotherapy in lung cancer,
discuss novel targets… explore the intersection between DNA repair defects and immunotherapy. …

… immunotherapy, the mortality rate of lung cancer has dramatically decreased. However, lung
cancer remains the leading cause of cancer … adenocarcinoma 2 . Therefore, finding new …

… , and potential as immunotherapy candidates were examined … to the prognosis and
immunotherapeutic targets of LUAD. … cells, and immunotherapy for lung cancer presently includes …

… Chemo-immunotherapy is now considered the pennant of care for NSCLC and SCLC; … of
immunotherapy in NSCLC and SCLC in this review, along with an emphasis on newer targets …

… , including lung adenocarcinoma. Citation21 – Citation26 … of all CC chemokine receptors as
targets and biomarkers in LUAD … as clinical markers and immunotherapeutic targets in LUAD …

… immunotherapy targets in melanoma (18). Our current study is the first in vivo CRISPR screen
to identify novel immunotherapy targets in lung cancer … targets for cancer immunotherapy. …

… Because Livin/ML-IAP is expressed in lung cancer cells but not in normal tissues, we
hypothesized that it might be a suitable target for tumor immunotherapy. Immune tolerance toward …

… of immunotherapy that represents a radical shift to cancer treatment [6]. Lung cancer was …
pathways has revolutionized the immunotherapeutic approaches of lung cancer. There are …